Whitehawk TherapeuticsWHWK
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 48 institutions reported holding Whitehawk Therapeutics Inc. (WHWK) in their 13F filings, up 7 from Q3 2025. 10 opened new positions and 5 sold out. The largest holders were QVT Financial LP ($10.6M), Orbimed Advisors LLC ($10.1M) and Montanova Capital, LLC ($9.0M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Whitehawk Therapeutics Inc.
- CUSIP
- 00032Q104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $2.3M |
| Exits | 5 | $805K |
All 13F filers, Q3 2025 → Q4 2025: 2,481,543 shares bought and 502,722 shares sold, net +1,978,821 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 48 holders
| QVT Financial LP | 1.02% | No change | 4,615,709 | $10.6M |
| Orbimed Advisors LLC | 0.21% | No change | 4,166,000 | $10.1M |
| Montanova Capital, LLC | 0.22% | No change | 3,700,000 | $9.0M |
| Acuta Capital Partners, LLC | 5.60% | No change | 3,410,402 | $8.3M |
| Avoro Capital Advisors LLC | 0.07% | No change | 2,849,402 | $6.9M |
| KVP Capital Advisors, LP | 5.41% | — | 2,165,997 | $5.2M |
| Siren, L.L.C. | 0.15% | No change | 2,082,000 | $5.0M |
| Yu Fan | 5.43% | No change | 2,070,000 | $5.0M |
| Vanguard Group Inc. | 0.00% | Add +18.4% | 1,590,117 | $3.8M |
| Stempoint Capital LP | 0.61% | Add +244.0% | 1,458,807 | $3.5M |
| Acorn Capital Advisors, LLC | 0.93% | No change | 1,139,363 | $2.8M |
| Ally Bridge Group (NY) LLC | 3.14% | No change | 817,939 | $2.0M |
| Renaissance Technologies | 0.00% | Reduce -3.6% | 440,722 | $1.1M |
| Geode Capital Management, LLC | 0.00% | Add +11.4% | 425,440 | $1.0M |
| Two Sigma Investments, LP | 0.00% | New | 309,865 | $750K |
| BlackRock, Inc. | 0.00% | Add +1.0% | 299,011 | $724K |
| Eversept Partners, LP | 0.04% | New | 260,259 | $630K |
| Bridgeway Capital Management, LLC | 0.01% | No change | 215,284 | $521K |
| State Street Corp. | 0.00% | Add +111.7% | 145,537 | $352K |
| Susquehanna International Group, LLP | 0.00% | New | 110,083 | $266K |
| Northern Trust Corp. | 0.00% | Add +43.4% | 103,452 | $250K |
| Citadel Advisors | 0.00% | Reduce -29.4% | 98,950 | $239K |
| ADAR1 Capital Management, LLC | 0.01% | New | 77,593 | $188K |
| Qube Research & Technologies Ltd | 0.00% | New | 72,348 | $175K |
| Jane Street Group, LLC | 0.00% | Add +177.3% | 69,931 | $169K |
| Marshall Wace, LLP | 0.00% | New | 67,959 | $164K |
| Two Sigma Advisers, LP | 0.00% | New | 42,400 | $103K |
| UBS Group AG | 0.00% | Add +424.2% | 29,844 | $72K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -35.1% | 28,641 | $69K |
| ABG Innovation Capital Partners III GP Ltd | 100.00% | No change | 26,666 | $65K |
| Acadian Asset Management LLC | 0.00% | Reduce -6.0% | 24,634 | $58K |
| Prelude Capital Management, LLC | 0.00% | New | 18,796 | $45K |
| XTX Topco Ltd | 0.00% | Reduce -20.6% | 15,704 | $38K |
| Quadrature Capital Ltd | 0.00% | New | 11,447 | $28K |
| Morgan Stanley | 0.00% | Add +264.9% | 6,748 | $16K |
| US Bancorp \de | 0.00% | No change | 3,333 | $8K |
| Osaic Holdings, Inc. | 0.00% | No change | 3,070 | $7K |
| Bartlett & Co. Wealth Management LLC | 0.00% | No change | 1,333 | $3K |
| Torren Management, LLC | 0.00% | — | 1,254 | $3K |
| Bank of America Corp. | 0.00% | Add +793.5% | 411 | $995 |
| Russell Investments Group, Ltd. | 0.00% | No change | 386 | $934 |
| TD Waterhouse Canada Inc. | 0.00% | No change | 232 | $561 |
| BNP Paribas Financial Markets | 0.00% | No change | 160 | $387 |
| JPMorgan Chase & Co. | 0.00% | Reduce -71.3% | 121 | $293 |
| Group One Trading LLC | 0.00% | New | 100 | $242 |
| SBI Securities Co., Ltd. | 0.00% | No change | 19 | $46 |
| Parallel Advisors, LLC | 0.00% | No change | 8 | $19 |
| Cwm, LLC | 0.00% | No change | 25 | $0 |
"% of holder's portfolio" is WHWK's weight in each manager's 13F, not the share of Whitehawk Therapeutics Inc. the manager owns.